October 24, 2012 Non Regulatory InDex Pharmaceuticals Granted Japanese Patent for Novel Treatment of Steroid-Resistant Inflammation Read more
October 24, 2012 Non Regulatory InDex Pharmaceuticals beviljas japanskt patent för ny behandling av steroidresistent inflammation Read more
August 30, 2012 Non Regulatory InDex Pharmaceuticals Strengthens IP Position for Kappaproct Read more
August 30, 2012 Non Regulatory InDex Pharmaceuticals utökar patentportföljen för läkemedelskandidaten Kappaproct Read more
July 9, 2012 Non Regulatory InDex publish positive results from Kappaproct Compassionate Use program Read more
June 19, 2012 Non Regulatory Kappaproct minskar behovet av kirurgiskt ingrepp för patienter med svår ulcerös kolit Read more
June 19, 2012 Non Regulatory Kappaproct Drastically Reduces the Need for Colectomy in Patients with Severe Ulcerative Colitis Read more
May 29, 2012 Non Regulatory InDex Pharmaceuticals utser Stig Løkke Pedersen till styrelseledamot Read more
May 29, 2012 Non Regulatory InDex Pharmaceuticals Appoints Stig Løkke Pedersen as Board Member Read more
April 26, 2012 Non Regulatory InDex Pharmaceuticals Granted US Patent for Novel Treatment of Steroid-Resistant Inflammation Read more
April 26, 2012 Non Regulatory InDex Pharmaceuticals beviljas amerikanskt patent för ny behandling av steroidresistent inflammation Read more
March 20, 2012 Non Regulatory InDex Pharmaceuticals utvecklar companion diagnostics för ny ulcerös kolit behandling Read more
March 20, 2012 Non Regulatory InDex Pharmaceuticals develops companion diagnostic test for new ulcerative colitis therapy. Read more
March 6, 2012 Non Regulatory InDex Pharmaceuticals Starts Phase III COLLECT Study with Kappaproct Read more
March 6, 2012 Non Regulatory InDex Pharmaceuticals startar fas III studien COLLECT för Kappaproct Read more